Key Blood Screening Market Players:
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories (U.S.)
- Grifols (Spain)
- Bio-Rad Laboratories (U.S.)
- Thermo Fisher Scientific (U.S.)
- Siemens Healthineers (Germany)
- Becton Dickinson (BD) (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Hologic (U.S.)
- QuidelOrtho (U.S.)
- Danaher (U.S.)
- BioMérieux (France)
- TransAsia Bio-Medicals (India)
- SD Biosensor (South Korea)
- Werfen (Spain)
The global market is extremely dominated by key players, including Grifols, Abbott, and Roche, all of which jointly account for a generous global share, through NAT automation and leadership. Besides, AI-powered investments, emerging economies, and pathogen inactivation technology are a few strategies that are readily adopted by all these organizations. Through effective investments, Roche successfully reduced false positives, followed by Abbott offering NAT test services in India, with the pathogen inactivation by Grifols, there has been capturing of the majority of the Europe-based plasma market, thus suitable for the overall market’s growth.
Here is a list of key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of the blood screening market was over USD 4.2 billion.
The market size for the blood screening market is projected to reach USD 11.8 billion by the end of 2035 expanding at a CAGR of 12.2% during the forecast period i.e., between 2026-2035.
The major players in the market are Roche, Abbott, Grifols, Bio-Rad, Thermo Fisher, Siemens Healthineers, and others.
In terms of the test type segment, the automated screening segment is anticipated to garner the largest market share of 59.3% by 2035 and display lucrative growth opportunities during 2026-2035.
The market in North America is projected to hold the largest market share of 41.5% by the end of 2035 and provide more business opportunities in the future.
